"World's Most Complete Market Research Reports Repository"

Global Hip Arthroplasty Market, Forecast Till 2025

  • Category : Healthcare & Pharma
  • |
  • ID : 598426
  • |
  • Publishe Date : August 2018
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Hip Arthroplasty Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025. The market is growing by increase in prevalence of Osteoarthritis and Rheumatoid Arthritis across the globe.

Patients shift to minimally invasive procedures from traditional procedures will considerably increase the global Hip Arthroplasty Market during the study period. Another factors contributing to market growth are increase in healthcare awareness among population and increase in geriatric population. Another more important factor for market growth is the growth of medical tourism. Research & Developments and technological advancements in products will provide numerous opportunity for market growth during the forecast period.

Stringent government regulations, post-operative complications and high costs are some of the factors that will affect the global Hip Arthroplasty Market negatively to certain extent.

The Total Hip Arthroplasty accounted for the largest market share in 2017 and is expected to grow considerably during the projected period. The Total Hip Arthroplasty is expected to witness high growth rate due to personalized or custom made implants and growing need of implants.

Some of the key players operating in this market include Zimmer Biomet, DePuy Synthes, Smith and Nephew, Stryker Corporation, Aesculap Implants Systems,LLC, Exactech, Inc, MicroPort Scientific, CONMED, DJO Global Inc., OMNIlife Science Inc, and Others.

Key Benefits of the Report:
? Global, Regional, Country, Product Type, and Component Type Market Size and Forecast from 2014-2025
? Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
? Identification of key companies that can influence this market on a global and regional scale
? Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
? Detailed insights on emerging regions, Product Type & Component Type, and competitive landscape with qualitative and quantitative information and facts

Target Audience:
* Hip Arthroplasty manufacturers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity production, spending were taken into consideration.
We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
? Original Equipment Manufacturer,
? Component Supplier,
? Distributors,
? Government Body & Associations, and
? Research Institute

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

2 METHODOLOGY AND MARKET SCOPE
2.1 Research Methodology
2.2 Research Scope & Assumptions

3 HIP ARTHROPLASTY MARKET ? INDUSTRY OUTLOOK
3.1 Market Segmentation and Scope
3.2 Market Size & Growth Prospects
3.3 Hip Arthroplasty Market ? Value Chain / Supply Chain Analysis
3.3.1 Company Landscape
3.4 Hip Arthroplasty Market ? Market Dynamics
3.4.1 Market Driver
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Hip Arthroplasty Market Company Market Share, 2017
3.6 Hip Arthroplasty Market ? Porter?s Five Forces Analysis
3.7 Hip Arthroplasty Market ? Pestel Analysis

4 HIP ARTHROPLASTY MARKET PRODUCT TYPE OUTLOOK
4.1 Hip Arthroplasty Market Share by Product Type, 2016 & 2025
4.2 Total
4.3 Partial
4.4 Hip Resurfacing
4.5 Revision

5 HIP ARTHROPLASTY MARKET COMPONENT TYPE OUTLOOK
5.1 Hip Arthroplasty Market Share by Component Type, 2016 & 2025
5.2 Ace tabular cup systems
5.3 Hip stem systems
5.4 Revision accessories and components

6 HIP ARTHROPLASTY MARKET REGIONAL OUTLOOK
6.1 Hip Arthroplasty Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America Hip Arthroplasty Market, 2014 - 2025
6.2.2 North America Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.2.3 North America Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.2.5 U.S.
6.2.5.1 U.S. Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.2.5.2 U.S. Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.2.6 Canada
6.2.6.1 Canada Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.2.6.2 Canada Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.3 Europe
6.3.1 Europe Hip Arthroplasty Market, 2014 ? 2025
6.3.2 Europe Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.3.3 Europe Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.3.5 Germany
6.3.5.1 Germany Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.3.5.2 Germany Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.3.6 UK
6.3.6.1 UK Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.3.6.2 UK Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.4 Asia Pacific
6.4.1 Asia Pacific Hip Arthroplasty Market, 2014 - 2025
6.4.2 Asia Pacific Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.4.3 Asia Pacific Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.4.5 Australia
6.4.5.1 Australia Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.4.5.2 Australia Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.4.6 New Zealand
6.4.6.1 New Zealand Hip Arthroplasty Market, By Product Type, 2014 -
2025
6.4.6.2 New Zealand Hip Arthroplasty Market, By Component Type, 2014 -2025
6.4.6.3 New Zealand Hip Arthroplasty Market, By End-Use, 2014 -2025
6.4.7 China
6.4.7.1 China Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.4.7.2 China Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.4.8 India
6.4.8.1 India Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.4.8.2 India Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.4.9 Japan
6.4.9.1 Japan Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.4.9.2 Japan Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.5 South America
6.5.1 South America Hip Arthroplasty Market, 2014 - 2025
6.5.2 South America Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.5.3 South America Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.5.5 Brazil
6.5.5.1 Brazil Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.5.5.2 Brazil Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.5.6 Mexico
6.5.6.1 Mexico Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.5.6.2 Mexico Hip Arthroplasty Market, By Component Type, 2014 - 2025
6.6 MEA
6.6.1 MEA Hip Arthroplasty Market, 2014 - 2025
6.6.2 MEA Hip Arthroplasty Market, By Product Type, 2014 - 2025
6.6.3 MEA Hip Arthroplasty Market, By Component Type, 2014 - 2025
7 COMPETITIVE LANDSCAPE
7.1 Zimmer Biomet
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Stryker Corporation
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 DuPay Synthes
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Smith and Nephew
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Aesculap Implants Systems,LLC
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Exactech, Inc
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives
7.7 MicroPort Scientific
7.7.1 Company overview
7.7.2 Financial performance
7.7.3 Product benchmarking
7.7.4 Strategic initiatives
7.8 CONMED
7.8.1 Company overview
7.8.2 Financial performance
7.8.3 Product benchmarking
7.8.4 Strategic initiatives
7.9 DJO Global Inc
7.9.1 Company overview
7.9.2 Financial performance
7.9.3 Product benchmarking
7.9.4 Strategic initiatives
7.10 OMNIlife Science Inc
7.10.1 Company overview
7.10.2 Financial performance
7.10.3 Product benchmarking
7.10.4 Strategic initiatives

End of the report
Disclaimer

Content are not available

Choose License Type